FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Angélica Corral

Research Profile

Disorders

HIV Infections

Living Beings

HIV-1
HIV

Chemicals & Drugs

Physiology

Geographic Areas

Spain

Concepts & Ideas

Procedures

CD4 Lymphocyte Count

Co-author Network

Publications

TOP 3
Mariola López; Alejandra Peris; Jesús San Román; Vicente Soriano; Eugenia Vispo; Angélica Corral; Dolores Herrero; Jose Miguel Benito
Short communication high risk of endothelial dysfunction in HIV individuals may result from deregulation of circulating endothelial cells and endothelial progenitor cells.
Eduardo Seclén; María Del Mar González; Angélica Corral; Carmen de Mendoza; Vincent Soriano; Eva Poveda
High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor.
Carmen de Mendoza; Carolina Garrido; Eva Poveda; Angélica Corral; Natalia Zahonero; Ana Treviño; Lourdes Anta; Vincent Soriano
Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Angélica Corral (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mariola López; Alejandra Peris; Jesús San Román; Vicente Soriano; Eugenia Vispo; Angélica Corral; Dolores Herrero; Jose Miguel Benito
Short communication high risk of endothelial dysfunction in HIV individuals may result from deregulation of circulating endothelial cells and endothelial progenitor cells.
AIDS research and human retroviruses 2012;28(7):656-9.
2010: Eduardo Seclén; María Del Mar González; Angélica Corral; Carmen de Mendoza; Vincent Soriano; Eva Poveda
High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor.
AIDS (London, England) 2010;24(3):467-9.
2009: Carmen de Mendoza; Carolina Garrido; Eva Poveda; Angélica Corral; Natalia Zahonero; Ana Treviño; Lourdes Anta; Vincent Soriano
Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain.
AIDS research and human retroviruses 2009;25(10):967-72.
2009: Judit Morello; Carmen de Mendoza; Vincent Soriano; Lourdes Anta; Gema González-Pardo; Angélica Corral; Francisco Blanco; Inmaculada Jiménez-Nácher; Juan González-Lahoz; Sonia Rodríguez-Novoa
Use of different inhibitory quotients to predict early virological response to tipranavir in antiretroviral-experienced human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 2009;53(10):4153-8.
2009: Carolina Garrido; Natalia Zahonero; Angélica Corral; Miguel Arredondo; Vincent Soriano; Carmen de Mendoza
Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests.
Journal of clinical microbiology 2009;47(4):1031-6.
2008: Carmen de Mendoza; Inmaculada Jiménez-Nacher; Carolina Garrido; Pablo Barreiro; Eva Poveda; Angélica Corral; Natalia Zahonero; Juan González-Lahoz; Vincent Soriano
Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(11):1782-5.
2008: Eva Poveda; Carmen de Mendoza; Neil Parkin; Sunny Choe; Pilar García-Gasco; Angélica Corral; Vincent Soriano
Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes.
AIDS (London, England) 2008;22(5):611-6.
2008: Carmen de Mendoza; Carolina Garrido; Angélica Corral; Natalia Zahonero; Vincent Soriano
Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance.
AIDS (London, England) 2008;22(2):311-3.
2007: Eva Poveda; Carolina Garrido; Carmen de Mendoza; Angélica Corral; Julio Cobo; Juan González-Lahoz; Vincent Soriano
Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors.
The Journal of antimicrobial chemotherapy 2007;60(6):1409-10.
2007: Silvina Masciotra; Carolina Garrido; Ae Youngpairoj; Amanda McNulty; Natalia Zahonero; Angélica Corral; Walid Heneine; Carmen de Mendoza; J Gerardo García-Lerma
High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
AIDS (London, England) 2007;21(18):2503-11.
2007: Eva Poveda; Carmen de Mendoza; Luz Martin-Carbonero; Angélica Corral; Verónica Briz; Juan González-Lahoz; Vincent Soriano
Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors.
The Journal of antimicrobial chemotherapy 2007;60(4):885-8.
2007: Eva Poveda; Verónica Briz; Carmen de Mendoza; José Benito; Angélica Corral; Natalia Zahonero; Sara Lozano; Juan González-Lahoz; Vincent Soriano
Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy.
Journal of medical virology 2007;79(8):1040-6.
2007: Carmen de Mendoza; Carolina Garrido; Angélica Corral; German Ramírez-Olivencia; Inmaculada Jiménez-Nacher; Natalia Zahonero; Juan Gonzalez-Lahoz; Vincent Soriano
Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients.
AIDS research and human retroviruses 2007;23(7):879-85.
2006: Carmen de Mendoza; Luisa Valer; Lee Bacheler; Theresa Pattery; Angélica Corral; Vincent Soriano
Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance.
AIDS (London, England) 2006;20(7):1071-4.
2006: Sonia Rodríguez-Nóvoa; Pablo Barreiro; Ana Rendón; Ana Barrios; Angélica Corral; Inmaculada Jiménez-Nacher; Juan González-Lahoz; Vincent Soriano
Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(2):291-5.
2005: Julie Sheldon; Angélica Corral; Berta Rodés; Stefan Mauss; Jürgen Rockstroh; Florian Berger; Carolynne Schwarze-Zander; Vincent Soriano
Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir.
AIDS (London, England) 2005;19(17):2036-8.
2005: Carmen de Mendoza; Carmen Rodriguez; Javier Colomina; Concepción Tuset; Federico Garcia; José María Eiros; Angélica Corral; Pilar Leiva; Jesús Aguero; Julián Torre-Cisneros; José Pedreira; Isabel Viciana; Jorge del Romero; Ana Saez; Raúl Ortiz De Lejarazu; Vincent Soriano
Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(9):1350-4.
2005: Carmen de Mendoza; Carmen Rodriguez; José María Eiros; Javier Colomina; Federico Garcia; Pilar Leiva; Julián Torre-Cisneros; Jesús Aguero; José Pedreira; Isabel Viciana; Angélica Corral; Jorge del Romero; Raúl Ortiz De Lejarazu; Vincent Soriano
Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(2):227-32.
2005: Carmen de Mendoza; Luz Martín-Carbonero; Oscar Gallego; Angélica Corral; Juan González-Lahoz; Vincent Soriano
Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.
Journal of medical virology 2005;76(1):1-6.
2005: Oscar Gallego; Carmen de Mendoza; Angélica Corral; Ana Barrios; Vincent Soriano
Estimated extent of cross-resistance to ritonavir-boosted protease inhibitors among protease inhibitors-experienced patients: implications for tipranavir use.
AIDS patient care and STDs 2005;19(2):67-9.
2004: Luisa Valer; Luz Martín-Carbonero; Carmen de Mendoza; Angélica Corral; Vincent Soriano
Predictors of selection of K65R: tenofovir use and lack of thymidine analogue mutations.
AIDS (London, England) 2004;18(15):2094-6.
2004: Daniel González de Requena; Oscar Gallego; Angélica Corral; Inmaculada Jiménez-Nácher; Vincent Soriano
Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations.
AIDS (London, England) 2004;18(15):2091-4.
2004: Carmen de Mendoza; Carmen Rodriguez; Angélica Corral; Jorge del Romero; Oscar Gallego; Vincent Soriano
Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(8):1231-8.
2004: Oscar Gallego; Luz Martin-Carbonero; Jesús Aguero; Carmen de Mendoza; Angélica Corral; Vincent Soriano
Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals.
Journal of virological methods 2004;121(1):115-8.
2004: Oscar Gallego; Carmen de Mendoza; Angélica Corral; Vincent Soriano
Prevalence of drug resistance genotypes causing broad cross-resistance to nucleos(t)ide analogues.
AIDS (London, England) 2004;18(4):689-90.
2003: Daniel González de Requena; Oscar Gallego; Carmen de Mendoza; Angélica Corral; Inmaculada Jiménez-Nácher; Vincent Soriano
Indinavir plasma concentrations and resistance mutations in patients experiencing early virological failure.
AIDS research and human retroviruses 2003;19(6):457-9.
2003: Oscar Gallego; Angélica Corral; Carmen de Mendoza; Juan Gonzalez-Lahoz; Vincent Soriano
High rate of resistance to antiretroviral drugs among HIV-infected prison inmates.
Medical science monitor : international medical journal of experimental and clinical research 2003;9(6):CR217-21.
2003: Oscar Gallego; Carmen de Mendoza; Angélica Corral; Vincent Soriano
Low rate of HIV-1 codon 215 revertants in antiretroviral-experienced patients.
AIDS (London, England) 2003;17(6):919-21.
2003: Oscar Gallego; Carmen de Mendoza; Angélica Corral; Vincent Soriano
Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients.
Journal of clinical microbiology 2003;41(3):1245-7.
2002: Carmen de Mendoza; Jorge del Romero; Carmen Rodríguez; Angélica Corral; Vincent Soriano
Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid.
AIDS (London, England) 2002;16(13):1830-2.
2002: Oscar Gallego; Angélica Corral; Carmen de Mendoza; Berta Rodés; Vincent Soriano
Prevalence of G333D/E in naive and pretreated HIV-infected patients.
AIDS research and human retroviruses 2002;18(12):857-60.
2002: Oscar Gallego; Angélica Corral; Carmen de Mendoza; Vincent Soriano
Prevalence of the HIV protease mutation N88S causing hypersensitivity to amprenavir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(9):1288-9.
2000: Oscar Gallego; C Briones; Angélica Corral; V Soriano
Prevalence of novel lamivudine-resistant genotypes (E44D/A, V118I) in naive and pretreated HIV-infected individuals.
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):95-6.